Position in EYPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,815,236
-$9,313,607 QoQ
Shares Held
336,730
-69.3% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 188 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. EYPT ranks #164 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in EYPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,815,236 | 336,730 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,128,843 | 1,096,109 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,086,977 | 223,699 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $13,928,555 | 978,129 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,364,658 | 782,642 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $4,683,478 | 864,111 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,553,188 | 745,395 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $14,511,866 | 1,816,254 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $19,599,329 | 2,252,797 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $27,741,513 | 1,342,115 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $30,479,707 | 1,318,897 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,093,197 | 136,821 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $760,586 | 87,424 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $262,652 | 89,339 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $85,697 | 24,485 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $79,437 | 10,043 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $92,162 | 11,711 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $112,361 | 9,248 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $243,488 | 19,893 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $64,394 | 6,180 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $150,528 | 16,744 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $30,581 | 3,010 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,225 | 2,010 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $81,039 | 155,847 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $118,579 | 156,028 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $143,538 | 140,725 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||